Key Points
- Jonathan Rothberg sold 674,758 shares at an average price of $3.27 for proceeds of about $2.21M, reducing his ownership by 55.32% to 544,894 shares valued at roughly $1.78M.
- BFLY opened at $3.08 with a market cap of $776.75M and a 52‑week range of $1.32–$4.98; analysts' consensus price target is $3.00 with an average "Hold" rating.
- Butterfly reported Q3 EPS of -$0.04 (beats) and revenue of $21.49M, but remains unprofitable with a negative net margin of 90.31% and analysts projecting about -0.35 EPS for the year.
Butterfly Network, Inc. (NYSE:BFLY - Get Free Report) Director Jonathan Rothberg sold 442,539 shares of the firm's stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $3.13, for a total transaction of $1,385,147.07. Following the transaction, the director owned 797,970 shares in the company, valued at $2,497,646.10. This represents a 35.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Butterfly Network Price Performance
Shares of NYSE:BFLY opened at $3.08 on Thursday. The stock's 50 day moving average price is $2.31 and its 200 day moving average price is $2.04. The stock has a market cap of $776.75 million, a price-to-earnings ratio of -9.32 and a beta of 2.65. Butterfly Network, Inc. has a 12 month low of $1.32 and a 12 month high of $4.98.
Butterfly Network (NYSE:BFLY - Get Free Report) last posted its quarterly earnings data on Friday, October 31st. The company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.02. Butterfly Network had a negative return on equity of 37.80% and a negative net margin of 90.31%.The company had revenue of $21.49 million for the quarter, compared to the consensus estimate of $21.23 million. Butterfly Network has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Butterfly Network, Inc. will post -0.35 EPS for the current year.
Institutional Investors Weigh In On Butterfly Network
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. TradeLink Capital LLC acquired a new position in shares of Butterfly Network in the first quarter worth $25,000. Ashton Thomas Private Wealth LLC purchased a new position in Butterfly Network in the second quarter valued at about $25,000. Ameriprise Financial Inc. purchased a new stake in shares of Butterfly Network during the 3rd quarter worth about $25,000. CTC Alternative Strategies Ltd. acquired a new stake in shares of Butterfly Network during the 1st quarter valued at about $29,000. Finally, Deutsche Bank AG bought a new stake in shares of Butterfly Network in the 1st quarter valued at approximately $31,000. Hedge funds and other institutional investors own 37.85% of the company's stock.
Analyst Upgrades and Downgrades
BFLY has been the subject of several research reports. Weiss Ratings restated a "sell (d-)" rating on shares of Butterfly Network in a research report on Wednesday, October 8th. Craig Hallum restated a "positive" rating and set a $2.00 target price on shares of Butterfly Network in a report on Monday, August 4th. Oppenheimer reaffirmed a "market perform" rating on shares of Butterfly Network in a report on Friday, August 1st. Finally, Wall Street Zen raised Butterfly Network from a "sell" rating to a "hold" rating in a research note on Sunday. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $3.00.
Get Our Latest Analysis on Butterfly Network
About Butterfly Network
(
Get Free Report)
Butterfly Network, Inc develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
